Timothy J. Scannell - 07 Jun 2023 Form 4 Insider Report for NovoCure Ltd (NVCR)

Role: Director
Signature: Steven Robbins, as attorney in fact for Scannell, Timothy J.
Issuer symbol: NVCR
Transactions as of: 07 Jun 2023
Net transactions value: $0
Form type: 4
Filing time: 09 Jun 2023, 16:05:12 UTC
Previous filing: 24 May 2023
Next filing: 03 Jul 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	NVCR	Restricted Stock Units	Award	$0	+3,853	+5137%	$0.000000	3,928	07 Jun 2023	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	NVCR	Stock Option (Right to Buy)	Award	$0	+6,277		$0.000000	6,277	07 Jun 2023	Ordinary Shares	6,277	$48.66	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	These restricted stock units are scheduled to vest 100% on the earlier of the following dates: (i) the first anniversary of the grant date or (ii) the day immediately preceding the Company's 2024 annual general meeting of shareholders.
F2	Options to buy 6,277 ordinary shares will fully vest and become exercisable on the earlier of the following dates: (i) the first anniversary of the grant date or (ii) the day immediately preceding the Company's 2024 annual general meeting of shareholders.